eClinical Tech News

Absci Corporation, a clinical-stage biopharmaceutical company, has initiated a Phase 1 trial of ABS-101, its AI-designed antibody for inflammatory...

Ascendis Pharma A/S released 52-week data from its ApproaCH trial, showing that TransCon CNP (navepegritide) improved growth and bone...

Connect Biopharma has initiated its Phase 2 Seabreeze STAT Asthma study to evaluate rademikibart’s safety and efficacy as an...

Revive Therapeutics is partnering with Defence R&D Canada (DRDC) to study Bucillamine as a potential treatment for nerve agent...

Ascendis Pharma A/S released 214-week data from its Phase 2 PaTH Forward Trial of TransCon PTH (palopegteriparatide) for adults...

Quantum BioPharma has completed the 90-day oral toxicity and toxicokinetic studies for its Multiple Sclerosis (MS) drug, Lucid-21-302 (Lucid-MS)....

Medera Inc., a clinical-stage biopharmaceutical company, announced that data from its Phase 1/2a MUSIC-HFpEF clinical trial investigating its gene...

Cognition Therapeutics presented preclinical data at ARVO demonstrating the potential of zervimesine (CT1812) to protect retinal cells from damage...

Tiziana Life SciencesLife Sciences announced positive results from a PET scan of an Alzheimer’s patient treated with their intranasal...

NurExone Biologic Inc. presented preclinical data at the ARVO annual meeting, demonstrating that its ExoPTEN therapy restored retinal activity...